01—Abstract
Summary
Summary of the 8-K filed November 24, 2025. Cited figures are marked; the original filing is the authoritative source.
Tenet Healthcare Corp ORATION (NYSE: THC) filed a Form 8-K dated November 21, 2025 (filed November 24, 2025) reporting a single event under Item 5.02 concerning board composition.
On November 21, 2025, Stephen H. Rusckowski notified the Company of his decision to resign from its board of directors, effective immediately. Following Mr. Rusckowski's resignation, the Board decreased its size from thirteen to twelve directors.
The filing does not state the reasons for his departure, nor does it name a successor or describe any compensatory arrangements. For investors, the filing is a governance notice rather than a financial disclosure. It contains no financial results, guidance, or operating metrics.
The filing is signed by Thomas A. Arnst, Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary.
02—Key points
Key Highlights
- Stephen H. Rusckowski resigned from the Tenet Healthcare Board of Directors, effective immediately, with notice given on November 21, 2025.
- The Board reduced its size from thirteen to twelve directors in connection with the resignation.
- Item 5.02 (Departure of Directors or Certain Officers) is the only item reported in the filing.
- The filing does not state the reason for Mr. Rusckowski's resignation.
- No successor director or board committee changes are disclosed in this filing.
- The filing contains no financial results, guidance, or operating data.
- The 8-K covers common stock (THC) and 6.875% Senior Notes due 2031 (THC31), both listed on the NYSE.
03—Questions
Frequently Asked Questions
Who resigned from Tenet Healthcare's board?
Stephen H. Rusckowski resigned from the Company's board of directors, effective immediately, after notifying the Company on November 21, 2025.
How did the resignation change the size of the board?
The Board decreased its size from thirteen to twelve directors in connection with Mr. Rusckowski's resignation.
Why did Mr. Rusckowski resign?
The filing does not state a reason for the resignation.
Does the filing name a replacement director or describe any compensation arrangements?
No. The filing does not name a successor or disclose any compensatory arrangements related to the resignation.
Does this filing contain financial results?
No. The filing reports only the board change under Item 5.02 and contains no financial results, guidance, or operating metrics.
04—Continue